Last reviewed · How we verify
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF (Rebalance-HF)
The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve. The study includes people who have heart failure with preserved ejection fraction (HFpEF). The goal is to learn whether this procedure, performed using the Satera Ablation System, may help improve symptoms and to better understand which patients may benefit most from this treatment in the future.
Details
| Lead sponsor | Axon Therapies, Inc. |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 150 |
| Start date | Fri Dec 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Aug 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Heart Failure With Preserved Ejection Fraction (HFpEF
Interventions
- Greater Splanchnic Nerve Ablation
- Sham Control
Countries
United States